• Pernix Therapeutics, Inc. (PTX) Announces Agreement to Acquire Great Southern Laboratories More...

• Pharming Group (PHGUF.PK) Announces Sale of US Facilities More...

• Ferring Pharmaceuticals, Inc. Acquires Licensing Rights for Elobixibat from Albireo More...

• Probi to Launch Gut and Immune Health Products in Taiwan With Alvogen More...

• Tethys Bioscience, Inc. and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention More...

• Paris Hospitals Group, AP-HP, and Biocitech SAS Sign Cooperation Agreement More...

• Targeted Growth, Inc. Adds New CEO, Board Members & Venture Funding More...

• Life Sciences Foundation Names Heather R. EricksonPresident and CEO More...

• Addex Therapeutics (ADXN.SW) Appoints Dr. Graham Dixon as Chief Scientific Officer and Head of Research More...

• Dendreon Corporation (DNDN) Release: John H. JohnsonAssumes Role of Chairman More...

• Infectious Disease Research Institute (IDRI) Expands Board, Adding Additional International Expertise With Dr Massimo Radaelli More...

• Bristol-Myers Squibb Company (BMY) to Announce Results for Second Quarter 2012 on July 25 More...

• Diamyd Medical AB: Quarterly Report III 11/12 More...

• ScinoPharm Building $37.6 Million Cancer Drug CMO in Tainan More...

• Osiris Therapeutics, Inc. (OSIR) Fibs About Clinical Trial Results More...

• Johnson & Johnson (JNJ) Recalls KY Liquibeads More...

• Eisai Company, Ltd. (ESALY.PK) Receives European Medicines Agency Approval to Market Zonegran Monotherapy for Treatment of Epilepsy More...

• Lupin Ltd. (LUPN.BO) Receives FDA Approval for Generic Ortho Tri-cyclen Lo® Tablets More...

• Mylan Inc. (MYL) Launches Generic Version of Lithobid® Tablets More...

• Mylan Inc. (MYL) Launches Generic Version of Clarinex® Allergy Medication More...

• Chelsea Therapeutics, Inc. (CHTP) Falls the Most in 3 Years Over Northera Update, Stock Down More...

• Johnson & Johnson (JNJ) Seeks Approval for Resistant TB Drug More...

• Agile Therapeutics, Inc. Announces FDA Accepts New Drug Application for Its Low-Dose, Once-Weekly Contraceptive Patch More...

• ThromboGenics NV (TBGNF) Announces FDA Accepts Filing and Grants Priority Review to Its Biologics License Application for Ocriplasmin Intravitreal Injection More...

• Little Addicts? Purdue Pharma L.P. to Test OxyContin on Kids More...

• MediciNova, Inc. Announces Scheduling of End-of-Phase 2 Meeting With FDA for MN-221 for the Treatment of Acute Exacerbations of Asthma More...

• Diamyd Medical AB Reports Results from Phase II Study in Cancer Pain More...

• Spectrum Pharmaceuticals, Inc. (SPPI) Launches Lucanthone Phase 2 Clinical Trial for the Treatment of Primary Glioblastoma Multiforme (GBM) More...

• Dramatic Change in Patient With ALS and MG Following Compassionate Use of BrainStorm Cell Therapeutics Inc.'s NurOwn™ Cell Therapy More...

• Kitty Litter Increases Risk of Suicide? University of Maryland Study More...

• Botox May Help Multiple Sclerosis Tremors, Royal Melbourne Hospital Study More...

• Antipsychotics in Pregnancy Up Diabetes Risk, Archives of General Psychiatry Reveals More...

• Family History of Schizophrenia, Bipolar Disorder May Up Kids' Risk for Autism, University of North Carolina School of Medicine Study More...

• Babies Born at 37 Weeks Should be Classed as Premature, Columbia University Study More...